Alcohol dependence is associated with high relapse rates following treatment.
Disulfiram is an established deterrent therapy. Its effectiveness depends on adherence.
Supervised disulfiram treatment has been shown to improve outcomes.
The Olita Study demonstrated improved abstinence rates when adherence was monitored.
These findings support the role of structured monitoring in recovery programmes.
​
ZenaMed Nexus has been developed to support these approaches through objective verification.
Return to work
User Documentation
ZenaMed provides structured documentation to support use of the Nexus system.
​​
A breathtaking solution to a common problem
The ZenaMed Nexus System
Three components operating as one:
-
Instrument — breath-based measurement
-
App — guided workflow and verification
-
Hub — monitoring and reporting
The ZenaMed Nexus System
Three components operating as one:
-
Instrument — breath-based measurement
-
App — guided workflow and verification
-
Hub — monitoring and reporting
The ZenaMed Nexus System
Three components operating as one:
-
Instrument — breath-based measurement
-
App — guided workflow and verification
-
Hub — monitoring and reporting
Alcohol dependence is associated with high relapse rates following treatment.
Disulfiram is an established deterrent therapy. Its effectiveness depends on adherence.
Supervised disulfiram treatment has been shown to improve outcomes.
The Olita Study demonstrated improved abstinence rates when adherence was monitored.
These findings support the role of structured monitoring in recovery programmes.
​
ZenaMed Nexus has been developed to support these approaches through objective verification.
Updates, Releases & Support
Information regarding system updates, app releases and documentation revisions will be published here.
Users should ensure they are using the latest version of the Nexus App and supporting materials.
​
All support enquiries are managed through structured forms to ensure appropriate routing.